VRBPAC to Review Covid Vaccine Proposals This Week

The US Food and Drug Administration (FDA) tasked its Vaccine and other Related Biologicals Advisory Committee (VRBPAC) to review proposals related to COVID-19 vaccines. Items scheduled for review include changing the primary vaccine doses to the bivalent vaccine and whether the composition and schedule for booster doses should be adjusted.